Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | COVID-19 | Research

Using outbreak data to estimate the dynamic COVID-19 landscape in Eastern Africa

Authors: Mark Wamalwa, Henri E. Z. Tonnang

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

The emergence of COVID-19 as a global pandemic presents a serious health threat to African countries and the livelihoods of its people. To mitigate the impact of this disease, intervention measures including self-isolation, schools and border closures were implemented to varying degrees of success. Moreover, there are a limited number of empirical studies on the effectiveness of non-pharmaceutical interventions (NPIs) to control COVID-19. In this study, we considered two models to inform policy decisions about pandemic planning and the implementation of NPIs based on case-death-recovery counts.

Methods

We applied an extended susceptible-infected-removed (eSIR) model, incorporating quarantine, antibody and vaccination compartments, to time series data in order to assess the transmission dynamics of COVID-19. Additionally, we adopted the susceptible-exposed-infectious-recovered (SEIR) model to investigate the robustness of the eSIR model based on case-death-recovery counts and the reproductive number (R0). The prediction accuracy was assessed using the root mean square error and mean absolute error. Moreover, parameter sensitivity analysis was performed by fixing initial parameters in the SEIR model and then estimating R0, β and γ.

Results

We observed an exponential trend of the number of active cases of COVID-19 since March 02 2020, with the pandemic peak occurring around August 2021. The estimated mean R0 values ranged from 1.32 (95% CI, 1.17–1.49) in Rwanda to 8.52 (95% CI: 3.73–14.10) in Kenya. The predicted case counts by January 16/2022 in Burundi, Ethiopia, Kenya, Rwanda, South Sudan, Tanzania and Uganda were 115,505; 7,072,584; 18,248,566; 410,599; 386,020; 107,265, and 3,145,602 respectively. We show that the low apparent morbidity and mortality observed in EACs, is likely biased by underestimation of the infected and mortality cases.

Conclusion

The current NPIs can delay the pandemic pea and effectively reduce further spread of COVID-19 and should therefore be strengthened. The observed reduction in R0 is consistent with the interventions implemented in EACs, in particular, lockdowns and roll-out of vaccination programmes. Future work should account for the negative impact of the interventions on the economy and food systems.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gorbalenya AE, Baker SC, Baric RS, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–44.CrossRef Gorbalenya AE, Baker SC, Baric RS, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–44.CrossRef
2.
go back to reference Hui DS, Azhar EI, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–6.PubMedPubMedCentralCrossRef Hui DS, Azhar EI, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–6.PubMedPubMedCentralCrossRef
3.
5.
go back to reference Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. The Lancet. 2020;395:470–3.CrossRef Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. The Lancet. 2020;395:470–3.CrossRef
6.
go back to reference Africa CDC. Coronavirus Disease 2019 (COVID-19)—Africa CDC. Africa CDC Dashboard. 2020;2019:1–7. Africa CDC. Coronavirus Disease 2019 (COVID-19)—Africa CDC. Africa CDC Dashboard. 2020;2019:1–7.
7.
8.
go back to reference Mboera LEG, Akipede GO, Banerjee A, et al. Mitigating lockdown challenges in response to COVID-19 in Sub-Saharan Africa. Int J Infect Dis. 2020;96:308–10.PubMedPubMedCentralCrossRef Mboera LEG, Akipede GO, Banerjee A, et al. Mitigating lockdown challenges in response to COVID-19 in Sub-Saharan Africa. Int J Infect Dis. 2020;96:308–10.PubMedPubMedCentralCrossRef
9.
go back to reference Gilbert M, Pullano G, Pinotti F, et al. Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study. Lancet. 2020;395:871–7.PubMedPubMedCentralCrossRef Gilbert M, Pullano G, Pinotti F, et al. Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study. Lancet. 2020;395:871–7.PubMedPubMedCentralCrossRef
10.
go back to reference Hagan JE, Ahinkorah BO, Seidu AA, et al. Africa’s COVID-19 situation in focus and recent happenings: a mini review. Front Public Health. 2020;8:937.CrossRef Hagan JE, Ahinkorah BO, Seidu AA, et al. Africa’s COVID-19 situation in focus and recent happenings: a mini review. Front Public Health. 2020;8:937.CrossRef
14.
go back to reference Flaxman S, Mishra S, Gandy A, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020; 1–8. Flaxman S, Mishra S, Gandy A, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020; 1–8.
19.
go back to reference Shetty RM, Achaiah NC, Subbarajasetty SB. R0 and re of COVID-19: can we predict when the pandemic outbreak will be contained? Indian J Crit Care Med. 2020;24:1125–7.PubMedPubMedCentralCrossRef Shetty RM, Achaiah NC, Subbarajasetty SB. R0 and re of COVID-19: can we predict when the pandemic outbreak will be contained? Indian J Crit Care Med. 2020;24:1125–7.PubMedPubMedCentralCrossRef
21.
go back to reference Baroyan OV, Rvachev LA, Basilevsky UV, et al. Computer modelling of influenza epidemics for the whole country (USSR). Adv Appl Probab. 1971;3:224–6.CrossRef Baroyan OV, Rvachev LA, Basilevsky UV, et al. Computer modelling of influenza epidemics for the whole country (USSR). Adv Appl Probab. 1971;3:224–6.CrossRef
22.
24.
go back to reference Kermack WO, McKendrick AG. Contributions to the mathematical theory of epidemics-I. Bull Math Biol. 1991;53:33–55.PubMed Kermack WO, McKendrick AG. Contributions to the mathematical theory of epidemics-I. Bull Math Biol. 1991;53:33–55.PubMed
25.
go back to reference Wang L, Zhou Y, He J, et al. An epidemiological forecast model and software assessing interventions on the COVID-19 epidemic in China. J Data Sci. 2021;18:409–32.CrossRef Wang L, Zhou Y, He J, et al. An epidemiological forecast model and software assessing interventions on the COVID-19 epidemic in China. J Data Sci. 2021;18:409–32.CrossRef
26.
go back to reference Wangping J, Ke H, Yang S, et al. Extended SIR prediction of the epidemics trend of COVID-19 in Italy and compared With Hunan, China. Front Med. 2020;7:169.CrossRef Wangping J, Ke H, Yang S, et al. Extended SIR prediction of the epidemics trend of COVID-19 in Italy and compared With Hunan, China. Front Med. 2020;7:169.CrossRef
27.
go back to reference Purkayastha S, Bhattacharyya R, Bhaduri R, et al. A comparison of five epidemiological models for transmission of SARS-CoV-2 in India. BMC Infect Dis. 2021;21:1–23.CrossRef Purkayastha S, Bhattacharyya R, Bhaduri R, et al. A comparison of five epidemiological models for transmission of SARS-CoV-2 in India. BMC Infect Dis. 2021;21:1–23.CrossRef
28.
go back to reference Butcher JC. Runge–Kutta Methods. In: Numerical Methods for Ordinary Differential Equations. John Wiley & Sons, Ltd, 2008, pp. 137–316. Butcher JC. Runge–Kutta Methods. In: Numerical Methods for Ordinary Differential Equations. John Wiley & Sons, Ltd, 2008, pp. 137–316.
29.
go back to reference Yu X, Dai Q. The Runge-Kutta DG finite element method and the KFVS scheme for compressible flow simulations. Numer Methods Partial Differ Equ. 2006;22:1455–78.CrossRef Yu X, Dai Q. The Runge-Kutta DG finite element method and the KFVS scheme for compressible flow simulations. Numer Methods Partial Differ Equ. 2006;22:1455–78.CrossRef
30.
go back to reference Mkhatshwa T, Mummert A. Modeling super-spreading events for infectious diseases: case study SARS. IAENG Int J Appl Math. 2011;41:82–8. Mkhatshwa T, Mummert A. Modeling super-spreading events for infectious diseases: case study SARS. IAENG Int J Appl Math. 2011;41:82–8.
31.
32.
33.
go back to reference Lourenço J, Paton R, Ghafari M, et al. Fundamental principles of epidemic spread highlight the immediate need for large-scale serological surveys to assess the stage of the SARS-CoV-2 epidemic. medRxiv. 2020; 2020.03.24.20042291. Lourenço J, Paton R, Ghafari M, et al. Fundamental principles of epidemic spread highlight the immediate need for large-scale serological surveys to assess the stage of the SARS-CoV-2 epidemic. medRxiv. 2020; 2020.03.24.20042291.
34.
go back to reference Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020;368:489–93.PubMedPubMedCentralCrossRef Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020;368:489–93.PubMedPubMedCentralCrossRef
35.
go back to reference Yuan HY, Han G, Yuan H, et al. The importance of the timing of quarantine measures before symptom onset to prevent COVID-19 outbreaks—illustrated by Hong Kong’s intervention model. medRxiv. 2020; 2020.05.03.20089482. Yuan HY, Han G, Yuan H, et al. The importance of the timing of quarantine measures before symptom onset to prevent COVID-19 outbreaks—illustrated by Hong Kong’s intervention model. medRxiv. 2020; 2020.05.03.20089482.
36.
go back to reference Mizumoto K, Kagaya K, Zarebski A, et al. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance. 2020;25:2000180.PubMedCentralCrossRef Mizumoto K, Kagaya K, Zarebski A, et al. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance. 2020;25:2000180.PubMedCentralCrossRef
38.
go back to reference Elizabeth Halloran M, Levin BR. Infectious diseases of humans: dynamics and control (pbk edn). Trends Microbiol. 1993;1:202–3.CrossRef Elizabeth Halloran M, Levin BR. Infectious diseases of humans: dynamics and control (pbk edn). Trends Microbiol. 1993;1:202–3.CrossRef
39.
go back to reference World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Who. 2021; 1–5. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Who. 2021; 1–5.
40.
go back to reference Johns Hopkins University. COVID-19 Map—Johns Hopkins Coronavirus Resource Center. Johns Hopkins Coronavirus Resource Center. 2020; 1. Johns Hopkins University. COVID-19 Map—Johns Hopkins Coronavirus Resource Center. Johns Hopkins Coronavirus Resource Center. 2020; 1.
41.
go back to reference Plummer M, Stukalov A, Denwood M. Bayesian Graphical Models using MCMC—package ‘rjags’. Comprehensive R Archive Network (CRAN), 2019. Plummer M, Stukalov A, Denwood M. Bayesian Graphical Models using MCMC—package ‘rjags’. Comprehensive R Archive Network (CRAN), 2019.
42.
go back to reference Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20:669–77.PubMedPubMedCentralCrossRef Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20:669–77.PubMedPubMedCentralCrossRef
43.
go back to reference Grace-Martin K. Assessing the fit of regression models. The Analysis Factor. 2016; 1–13. Grace-Martin K. Assessing the fit of regression models. The Analysis Factor. 2016; 1–13.
44.
go back to reference Gholamy A, Kreinovich V, Kosheleva O. Why 70/30 or 80/20 relation between training and testing sets: a pedagogical explanation. Dep Tech Reports. 2018; 1–6. Gholamy A, Kreinovich V, Kosheleva O. Why 70/30 or 80/20 relation between training and testing sets: a pedagogical explanation. Dep Tech Reports. 2018; 1–6.
45.
go back to reference Batool H, Tian L. Correlation determination between COVID-19 and weather parameters using time series forecasting: a case study in Pakistan. Math Probl Eng. 2021;2021:1–9.CrossRef Batool H, Tian L. Correlation determination between COVID-19 and weather parameters using time series forecasting: a case study in Pakistan. Math Probl Eng. 2021;2021:1–9.CrossRef
46.
go back to reference Bhaduri R, Kundu R, Purkayastha S, et al. Extending the Susceptible-Exposed-Infected-Removed(SEIR) Model to handle the high false negative rate and symptom-based administration of COVID-19 diagnostic tests: SEIR-fansy. medRxiv Prepr Serv Heal Sci 2020; 2020.09.24.20200238. Bhaduri R, Kundu R, Purkayastha S, et al. Extending the Susceptible-Exposed-Infected-Removed(SEIR) Model to handle the high false negative rate and symptom-based administration of COVID-19 diagnostic tests: SEIR-fansy. medRxiv Prepr Serv Heal Sci 2020; 2020.09.24.20200238.
47.
go back to reference Achaiah NC, Subbarajasetty SB, Shetty RM. R0 and re of COVID-19: can we predict when the pandemic outbreak will be contained? Indian J Crit Care Med. 2020;24:1125–7.PubMedPubMedCentralCrossRef Achaiah NC, Subbarajasetty SB, Shetty RM. R0 and re of COVID-19: can we predict when the pandemic outbreak will be contained? Indian J Crit Care Med. 2020;24:1125–7.PubMedPubMedCentralCrossRef
48.
go back to reference You C, Deng Y, Hu W, et al. Estimation of the time-varying reproduction number of COVID-19 outbreak in China. Int J Hyg Environ Health. 2020;228: 113555.PubMedPubMedCentralCrossRef You C, Deng Y, Hu W, et al. Estimation of the time-varying reproduction number of COVID-19 outbreak in China. Int J Hyg Environ Health. 2020;228: 113555.PubMedPubMedCentralCrossRef
50.
go back to reference Taghizadeh L, Karimi A, Heitzinger C. Uncertainty quantification in epidemiological models for the COVID-19 pandemic. Comput Biol Med. 2020;125: 104011.PubMedPubMedCentralCrossRef Taghizadeh L, Karimi A, Heitzinger C. Uncertainty quantification in epidemiological models for the COVID-19 pandemic. Comput Biol Med. 2020;125: 104011.PubMedPubMedCentralCrossRef
51.
go back to reference Ghosh D, Jonathan A, Mersha TB. COVID-19 pandemic: the African paradox. J Glob Health. 2020;10:1–6. Ghosh D, Jonathan A, Mersha TB. COVID-19 pandemic: the African paradox. J Glob Health. 2020;10:1–6.
53.
go back to reference Brand SPC, Aziza R, Kombe IK, et al. Forecasting the scale of the COVID-19 epidemic in Kenya. medRxiv. 2020; 2020.04.09.20059865. Brand SPC, Aziza R, Kombe IK, et al. Forecasting the scale of the COVID-19 epidemic in Kenya. medRxiv. 2020; 2020.04.09.20059865.
54.
go back to reference Mwalili S, Kimathi M, Ojiambo V, et al. Age-structured impact of mitigation strategies on COVID-19 severity and deaths in Kenya. ResearchSquare 2020; 1–14. Mwalili S, Kimathi M, Ojiambo V, et al. Age-structured impact of mitigation strategies on COVID-19 severity and deaths in Kenya. ResearchSquare 2020; 1–14.
56.
57.
go back to reference Iesa MAM, Osman MEM, Hassan MA, et al. SARS-CoV-2 and Plasmodium falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt. New Microbes New Infect. 2020;38: 100817.PubMedPubMedCentralCrossRef Iesa MAM, Osman MEM, Hassan MA, et al. SARS-CoV-2 and Plasmodium falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt. New Microbes New Infect. 2020;38: 100817.PubMedPubMedCentralCrossRef
61.
go back to reference Lucinde R, Mugo D, Bottomley C, et al. Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals Corresponding author + Contributed equally KEMRI-Wellcome Trust Research Programme. medRxiv 2021; 2021.02.05.21250735. Lucinde R, Mugo D, Bottomley C, et al. Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals Corresponding author + Contributed equally KEMRI-Wellcome Trust Research Programme. medRxiv 2021; 2021.02.05.21250735.
62.
go back to reference Brewster LM, Seedat YK. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review. BMC Med. 2013;11:1–16.CrossRef Brewster LM, Seedat YK. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review. BMC Med. 2013;11:1–16.CrossRef
63.
go back to reference Anjorin AA, Abioye AI, Asowata OE, et al. Comorbidities and the COVID-19 pandemic dynamics in Africa. Trop Med Int Heal. 2021;26:2–13.CrossRef Anjorin AA, Abioye AI, Asowata OE, et al. Comorbidities and the COVID-19 pandemic dynamics in Africa. Trop Med Int Heal. 2021;26:2–13.CrossRef
64.
go back to reference Kronbichler A, Kresse D, Yoon S, et al. Asymptomatic patients as a source of COVID-19 infections: a systematic review and meta-analysis. Int J Infect Dis. 2020;98:180–6.PubMedPubMedCentralCrossRef Kronbichler A, Kresse D, Yoon S, et al. Asymptomatic patients as a source of COVID-19 infections: a systematic review and meta-analysis. Int J Infect Dis. 2020;98:180–6.PubMedPubMedCentralCrossRef
68.
go back to reference Volz E, Hill V, McCrone JT, et al. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell. 2021;184:64-75.e11.PubMedPubMedCentralCrossRef Volz E, Hill V, McCrone JT, et al. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell. 2021;184:64-75.e11.PubMedPubMedCentralCrossRef
70.
go back to reference Alonso WJ, Viboud C, Simonsen L, et al. Seasonality of influenza in Brazil: a traveling wave from the amazon to the subtropics. Am J Epidemiol. 2007;165:1434–42.PubMedCrossRef Alonso WJ, Viboud C, Simonsen L, et al. Seasonality of influenza in Brazil: a traveling wave from the amazon to the subtropics. Am J Epidemiol. 2007;165:1434–42.PubMedCrossRef
71.
go back to reference Martins LD, da Silva I, Batista WV, et al. How socio-economic and atmospheric variables impact COVID-19 and influenza outbreaks in tropical and subtropical regions of Brazil. Environ Res. 2020;191: 110184.PubMedPubMedCentralCrossRef Martins LD, da Silva I, Batista WV, et al. How socio-economic and atmospheric variables impact COVID-19 and influenza outbreaks in tropical and subtropical regions of Brazil. Environ Res. 2020;191: 110184.PubMedPubMedCentralCrossRef
75.
go back to reference Kimathi M, Mwalili S, Ojiambo V, et al. Age-structured model for COVID-19: effectiveness of social distancing and contact reduction in Kenya. Infect Dis Model. 2021;6:15–23.PubMed Kimathi M, Mwalili S, Ojiambo V, et al. Age-structured model for COVID-19: effectiveness of social distancing and contact reduction in Kenya. Infect Dis Model. 2021;6:15–23.PubMed
Metadata
Title
Using outbreak data to estimate the dynamic COVID-19 landscape in Eastern Africa
Authors
Mark Wamalwa
Henri E. Z. Tonnang
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
COVID-19
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07510-3

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.